1. Home
  2. PEPG vs WEYS Comparison

PEPG vs WEYS Comparison

Compare PEPG & WEYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PEPG
  • WEYS
  • Stock Information
  • Founded
  • PEPG 2018
  • WEYS 1906
  • Country
  • PEPG United States
  • WEYS United States
  • Employees
  • PEPG N/A
  • WEYS N/A
  • Industry
  • PEPG Biotechnology: Pharmaceutical Preparations
  • WEYS Apparel
  • Sector
  • PEPG Health Care
  • WEYS Consumer Staples
  • Exchange
  • PEPG Nasdaq
  • WEYS Nasdaq
  • Market Cap
  • PEPG 317.6M
  • WEYS 294.5M
  • IPO Year
  • PEPG 2022
  • WEYS N/A
  • Fundamental
  • Price
  • PEPG $4.62
  • WEYS $28.01
  • Analyst Decision
  • PEPG Strong Buy
  • WEYS
  • Analyst Count
  • PEPG 6
  • WEYS 0
  • Target Price
  • PEPG $8.17
  • WEYS N/A
  • AVG Volume (30 Days)
  • PEPG 9.6M
  • WEYS 15.1K
  • Earning Date
  • PEPG 11-06-2025
  • WEYS 11-04-2025
  • Dividend Yield
  • PEPG N/A
  • WEYS 3.86%
  • EPS Growth
  • PEPG N/A
  • WEYS N/A
  • EPS
  • PEPG N/A
  • WEYS 2.69
  • Revenue
  • PEPG N/A
  • WEYS $281,051,000.00
  • Revenue This Year
  • PEPG N/A
  • WEYS N/A
  • Revenue Next Year
  • PEPG N/A
  • WEYS N/A
  • P/E Ratio
  • PEPG N/A
  • WEYS $10.41
  • Revenue Growth
  • PEPG N/A
  • WEYS N/A
  • 52 Week Low
  • PEPG $0.88
  • WEYS $25.51
  • 52 Week High
  • PEPG $9.37
  • WEYS $41.05
  • Technical
  • Relative Strength Index (RSI)
  • PEPG 63.02
  • WEYS 33.64
  • Support Level
  • PEPG $4.70
  • WEYS $29.61
  • Resistance Level
  • PEPG $5.20
  • WEYS $29.57
  • Average True Range (ATR)
  • PEPG 0.56
  • WEYS 0.79
  • MACD
  • PEPG 0.00
  • WEYS -0.18
  • Stochastic Oscillator
  • PEPG 59.00
  • WEYS 0.00

About PEPG PepGen Inc.

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.

About WEYS Weyco Group Inc.

Weyco Group Inc is a company, engaged in the manufacturing, designing, and distribution of footwear. The company designs and markets footwear for men, women, and children. It markets its apparel, accessories, and footwear under the brand names of Florsheim, Nunn Bush, Stacy Adams, BOGS, Rafters, and Forsake. The company organizes its business into two segments; the North American wholesale operations and the North American retail operations. The majority of the company's revenue is generated from the wholesale segment under which its products are sold to footwear, department, and specialty stores, as well as e-commerce retailers. The company has operational footprints in the United States which generates key revenue, Canada, Asia, South Africa, and Australia.

Share on Social Networks: